• Latest
  • Trending
  • All
  • News
  • Business
  • Lifestyle
Regeneron’s Drug Becomes First FDA-Approved Ebola Virus Treatment

Regeneron’s Drug Becomes First FDA-Approved Ebola Virus Treatment

October 14, 2020
VANESSA BATTAGLIA: Hegseth Is Right To Demand Afghanistan Withdrawal Accountability

VANESSA BATTAGLIA: Hegseth Is Right To Demand Afghanistan Withdrawal Accountability

June 1, 2025
LEIF LARSON: We Can’t Let Microsoft Unfairly Dominate The Tech Marketplace

LEIF LARSON: We Can’t Let Microsoft Unfairly Dominate The Tech Marketplace

June 1, 2025
STEVE MILLOY: Trump To Revive The Nuclear Power Industry

STEVE MILLOY: Trump To Revive The Nuclear Power Industry

June 1, 2025
Nonprofit Funded By Chinese Gov’t-Linked Entities Backs Blue State’s ‘Unconstitutional’ Climate Law

Nonprofit Funded By Chinese Gov’t-Linked Entities Backs Blue State’s ‘Unconstitutional’ Climate Law

May 31, 2025
Why On-And-Off Voters Who Backed Trump May Be GOP’s Midterm Silver Bullet

Why On-And-Off Voters Who Backed Trump May Be GOP’s Midterm Silver Bullet

May 31, 2025
MICHAEL LUCCI: US Multinationals Must Exit China

MICHAEL LUCCI: US Multinationals Must Exit China

May 31, 2025
CASEY RYAN: Loudoun County Is Back In The Election Year Headlines Again

CASEY RYAN: Loudoun County Is Back In The Election Year Headlines Again

May 31, 2025
DAVID BLACKMON: Did Trump And Hochul Just Swap An Offshore Wind Farm For A Pipeline?

DAVID BLACKMON: Did Trump And Hochul Just Swap An Offshore Wind Farm For A Pipeline?

May 31, 2025
Father Of DJ Daniel Gives Heartbreaking Health Update About Son

Father Of DJ Daniel Gives Heartbreaking Health Update About Son

May 30, 2025
Appeals Court Blocks Trump’s Push For Mass Federal Firings

Appeals Court Blocks Trump’s Push For Mass Federal Firings

May 30, 2025
Musk Leaves DOGE With a Black Eye — Literally 

Musk Leaves DOGE With a Black Eye — Literally 

May 30, 2025
Campaign Board Fines Cuomo $675,000 While Awarding Millions To Opponent

Campaign Board Fines Cuomo $675,000 While Awarding Millions To Opponent

May 30, 2025
  • Donald Trump
  • State of the Union
  • Elon Musk
  • Tariffs
  • Congress
  • Faith
  • Immigration
Sunday, June 1, 2025
  • Login
IJR
  • Politics
  • US News
  • Commentary
  • World News
  • Faith
  • Latest Polls
No Result
View All Result
IJR
No Result
View All Result
Home News

Regeneron’s Drug Becomes First FDA-Approved Ebola Virus Treatment

by Reuters
October 14, 2020 at 6:50 pm
in News
250 2
1
Regeneron’s Drug Becomes First FDA-Approved Ebola Virus Treatment

FILE PHOTO: The Regeneron Pharmaceuticals company logo is seen on a building at the company's Westchester campus in Tarrytown, New York, U.S. September 17, 2020. REUTERS/Brendan McDermid

491
SHARES
1.4k
VIEWS
Share on FacebookShare on Twitter

The U.S. Food and Drug Administration on Wednesday approved Regeneron Pharmaceuticals’ triple antibody cocktail as the first Ebola virus treatment, lending validation to similar drugs being developed for COVID-19.

Regeneron’s Inmazeb, an intravenous drug, has been approved for adults and children, after it was tested in 382 candidates with confirmed Zaire ebolavirus infection in a clinical trial, the health regulator said.

The drugmaker has said it is talking with the FDA about an emergency use authorization for its experimental dual antibody cocktail for COVID-19, which was given to U.S. President Donald Trump as part of his treatment regime.

The treatments are part of a class of drugs known as monoclonal antibodies, which are manufactured copies of antibodies that are one of the main weapons generated by the immune system to fight infections.

“Today’s action demonstrates the FDA’s ongoing commitment to responding to public health threats — both domestically and abroad — on the basis of science and data,” FDA Commissioner Stephen Hahn said in a media statement.

The FDA approved Ervebo, the first vaccine for the prevention of Ebola virus disease, in December 2019.

(Reporting by Deena Beasley and Vishwadha Chander in Bengaluru; Editing by Shinjini Ganguli)

Tags: Food and Drug Administration
Share196Tweet123
Reuters

Reuters

Reuters is an international news organization.

Advertisements

Top Stories June 10th
Top Stories June 7th
Top Stories June 6th
Top Stories June 3rd
Top Stories May 30th
Top Stories May 29th
Top Stories May 24th
Top Stories May 23rd
Top Stories May 21st
Top Stories May 17th

Join Over 6M Subscribers

We’re organizing an online community to elevate trusted voices on all sides so that you can be fully informed.





IJR

    Copyright © 2024 IJR

Trusted Voices On All Sides

  • About Us
  • GDPR Privacy Policy
  • Terms of Service
  • Editorial Standards & Corrections Policy
  • Subscribe to IJR

Follow Us

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Politics
  • US News
  • Commentary
  • World News
  • Faith
  • Latest Polls

    Copyright © 2024 IJR

Top Stories June 10th Top Stories June 7th Top Stories June 6th Top Stories June 3rd Top Stories May 30th Top Stories May 29th Top Stories May 24th Top Stories May 23rd Top Stories May 21st Top Stories May 17th